These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8290178)
21. Percutaneous estrogen in prevention of early postmenopausal bone loss in Chinese women. Sun A; Lin S; Yu W; Qin M; Chen F; Zhang Y; Wei Y; de Lignieres B Chin Med J (Engl); 2002 Dec; 115(12):1790-5. PubMed ID: 12622925 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. Dane C; Dane B; Cetin A; Erginbas M Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771 [TBL] [Abstract][Full Text] [Related]
23. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial. Schaefers M; Muysers C; Alexandersen P; Christiansen C Menopause; 2009; 16(3):559-65. PubMed ID: 19423999 [TBL] [Abstract][Full Text] [Related]
24. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449 [TBL] [Abstract][Full Text] [Related]
25. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Compston JE Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858 [TBL] [Abstract][Full Text] [Related]
26. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Brincat M; Versi E; Moniz CF; Magos A; de Trafford J; Studd JW Obstet Gynecol; 1987 Jul; 70(1):123-7. PubMed ID: 3601260 [TBL] [Abstract][Full Text] [Related]
27. Effect of hormone replacement therapy on bone quality in early postmenopausal women. Paschalis EP; Boskey AL; Kassem M; Eriksen EF J Bone Miner Res; 2003 Jun; 18(6):955-9. PubMed ID: 12817747 [TBL] [Abstract][Full Text] [Related]
28. Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density. Miller BE; De Souza MJ; Slade K; Luciano AA Menopause; 2000; 7(5):318-26. PubMed ID: 10993031 [TBL] [Abstract][Full Text] [Related]
29. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study. Khastgir G; Studd J; Holland N; Alaghband-Zadeh J; Fox S; Chow J J Clin Endocrinol Metab; 2001 Jan; 86(1):289-95. PubMed ID: 11232014 [TBL] [Abstract][Full Text] [Related]
30. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis]. Søgaard CH; Mosekilde L; Richards A; Mosekilde L Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640 [TBL] [Abstract][Full Text] [Related]
31. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Holland EF; Leather AT; Studd JW Br J Obstet Gynaecol; 1995 Mar; 102(3):238-42. PubMed ID: 7794850 [TBL] [Abstract][Full Text] [Related]
32. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. Banse X; Sims TJ; Bailey AJ J Bone Miner Res; 2002 Sep; 17(9):1621-8. PubMed ID: 12211432 [TBL] [Abstract][Full Text] [Related]
33. Hormonal therapy with estradiol and testosterone implants: bone protection? Britto R; Araújo L; Barbosa I; Silva L; Rocha S; Valente AP Gynecol Endocrinol; 2011 Feb; 27(2):96-100. PubMed ID: 20504104 [TBL] [Abstract][Full Text] [Related]
34. The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women. Studd JW; Holland EF; Leather AT; Smith RN Br J Obstet Gynaecol; 1994 Sep; 101(9):787-91. PubMed ID: 7947528 [TBL] [Abstract][Full Text] [Related]
35. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis. Ono S; Yamauchi M Ann Neurol; 1992 Mar; 31(3):305-10. PubMed ID: 1637138 [TBL] [Abstract][Full Text] [Related]
36. Distribution of collagen cross-links in normal human trabecular bone. Paschalis EP; Recker R; DiCarlo E; Doty SB; Atti E; Boskey AL J Bone Miner Res; 2003 Nov; 18(11):1942-6. PubMed ID: 14606505 [TBL] [Abstract][Full Text] [Related]
37. Effects of zoledronate on irradiated bone in vivo: analysis of the collagen types I, V and their cross-links lysylpyridinoline, hydroxylysylpyridinoline and hydroxyproline. Açil Y; Gierloff M; Behrens C; Möller B; Gassling V; Niehoff P; Wiltfang J; Simon M Calcif Tissue Int; 2013 Mar; 92(3):251-60. PubMed ID: 23179106 [TBL] [Abstract][Full Text] [Related]
38. The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants. Studd J; Savvas M; Waston N; Garnett T; Fogelman I; Cooper D Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1474-9. PubMed ID: 2240090 [TBL] [Abstract][Full Text] [Related]
39. The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: a prospective, controlled study. Välimäki MJ; Laitinen KA; Tähtelä RK; Hirvonen EJ; Risteli JP Am J Obstet Gynecol; 2003 Nov; 189(5):1213-20. PubMed ID: 14634543 [TBL] [Abstract][Full Text] [Related]
40. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Vedi S; Purdie DW; Ballard P; Bord S; Cooper AC; Compston JE Osteoporos Int; 1999; 10(1):52-8. PubMed ID: 10501780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]